help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, T. C.
Right arrow Articles by Ambinder, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, T. C.
Right arrow Articles by Ambinder, R. F.

American Journal of Pathology, Vol 138, 1461-1469, Copyright © 1991 by American Society for Investigative Pathology


REGULAR ARTICLES

Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens

TC Wu, RB Mann, JI Epstein, E MacMahon, WA Lee, P Charache, SD Hayward, RJ Kurman, GS Hayward and RF Ambinder
Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland.

The highly restricted expression of the Epstein-Barr virus (EBV) genome in malignancy has limited the use of EBV detection methods applicable to formalin-fixed paraffin-embedded carcinoma specimens. In EBV- transformed lymphocytes very short nonprotein coding EBV transcripts (EBERs) are expressed in much higher abundance (10(7) copies per cell) than other EBV latency transcripts. Using a 3H riboprobe, the authors demonstrated EBER1 expression in NASOPHARYNGEAL CARCINOMAS (NPCs) as well as in parotid salivary gland. Recognition of EBER1 expression was facilitated by the intensity of hybridization and its characteristic morphology (nuclear with nucleolar sparing). EBER1 expression was not demonstrated in other epithelial malignancies arising from mucosal surfaces (oropharynx, uterine cervix) from which EBV shedding has been detected. Repeat study of the NPC specimens with digoxigenin-labeled probe yielded hybridization signal with subcellular morphologic detail and without background in a 12-hour procedure. Thus the EBER1 transcript is an appropriate target for in situ hybridization detection of EBV in formalin-fixed paraffin-embedded carcinoma specimens.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
N. M. Alajez, J. D. Mocanu, W. Shi, M. C. Chia, C. J. Breitbach, A. B.Y. Hui, S. Knowles, J. C. Bell, P. Busson, K. Takada, et al.
Efficacy of Systemically Administered Mutant Vesicular Stomatitis Virus (VSV{Delta}51) Combined with Radiation for Nasopharyngeal Carcinoma
Clin. Cancer Res., August 1, 2008; 14(15): 4891 - 4897.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J.-C. Lin, W.-Y. Wang, K. Y. Chen, Y.-H. Wei, W.-M. Liang, J.-S. Jan, and R.-S. Jiang
Quantification of Plasma Epstein-Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma
N. Engl. J. Med., June 10, 2004; 350(24): 2461 - 2470.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G Bar-Sela, A Kuten, I Minkov, E Gov-Ari, and O Ben-Izhak
Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel
J. Clin. Pathol., March 1, 2004; 57(3): 290 - 293.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J.-C. Lin, K. Y. Chen, W.-Y. Wang, J.-S. Jan, W.-M. Liang, C.-S. Tsai, and Y.-H. Wei
Detection of Epstein-Barr Virus DNA in the Peripheral-Blood Cells of Patients With Nasopharyngeal Carcinoma: Relationship to Distant Metastasis and Survival
J. Clin. Oncol., May 15, 2001; 19(10): 2607 - 2615.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
M. R. Ortiz, G. Garijo, M. Adrados, E. Lopez-Bonet, D. Acero, and L. Bernado
Epstein-Barr Virus-Associated Cholangiocarcinoma with Lymphoepithelioma-Like Component
International Journal of Surgical Pathology, October 1, 2000; 8(4): 347 - 351.
[Abstract] [PDF]


Home page
Mol. Pathol.Home page
G Niedobitek
Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma
Mol. Pathol., October 1, 2000; 53(5): 248 - 254.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
G. Decaussin, F. Sbih-Lammali, Mireille de Turenne-Tessier, A. Bouguermouh, and T. Ooka
Expression of BARF1 Gene Encoded by Epstein-Barr Virus in Nasopharyngeal Carcinoma Biopsies
Cancer Res., October 1, 2000; 60(19): 5584 - 5588.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. A. Leachman, R. E. Tigelaar, M. Shlyankevich, M. D. Slade, M. Irwin, E. Chang, T. C. Wu, W. Xiao, S. Pazhani, D. Zelterman, et al.
Granulocyte-Macrophage Colony-Stimulating Factor Priming plus Papillomavirus E6 DNA Vaccination: Effects on Papilloma Formation and Regression in the Cottontail Rabbit Papillomavirus-Rabbit Model
J. Virol., September 15, 2000; 74(18): 8700 - 8708.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
K.-W. Lo, Y.M. D. Lo, S.-F. Leung, Y.-S. Tsang, L. Y.S. Chan, P. J. Johnson, N. M. Hjelm, J. C.K. Lee, and D. P. Huang
Analysis of Cell-free Epstein-Barr Virus-associated RNA in the Plasma of Patients with Nasopharyngeal Carcinoma
Clin. Chem., August 1, 1999; 45(8): 1292 - 1294.
[Full Text] [PDF]


Home page
J. Virol.Home page
J. D. Fingeroth, M. E. Diamond, D. R. Sage, J. Hayman, and J. L. Yates
CD21-Dependent Infection of an Epithelial Cell Line, 293, by Epstein-Barr Virus
J. Virol., March 1, 1999; 73(3): 2115 - 2125.
[Abstract] [Full Text]


Home page
BloodHome page
P. G. Murray, C. M. Constandinou, J. Crocker, L. S. Young, and R. F. Ambinder
Analysis of Major Histocompatibility Complex Class I, TAP Expression, and LMP2 Epitope Sequence in Epstein-Barr Virus-Positive Hodgkin's Disease
Blood, October 1, 1998; 92(7): 2477 - 2483.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. G. Horenstein, R. G. Nador, A. Chadburn, E. M. Hyjek, G. Inghirami, D. M. Knowles, and E. Cesarman
Epstein-Barr Virus Latent Gene Expression in Primary Effusion Lymphomas Containing Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus-8
Blood, August 1, 1997; 90(3): 1186 - 1191.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Quintanilla-Martinez, C. Lome-Maldonado, G. Ott, A. Gschwendtner, E. Gredler, E. Reyes, A. Angeles-Angeles, and F. Fend
Primary Non-Hodgkin's Lymphoma of the Intestine: High Prevalence of Epstein-Barr Virus in Mexican Lymphomas as Compared With European Cases
Blood, January 15, 1997; 89(2): 644 - 651.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A.I. Meisler, V. Schuster, T. Pukrop, and N. Raab-Traub
Epstein-Barr Virus and Nasopharyngeal Cancer
N. Engl. J. Med., January 11, 1996; 334(2): 122 - 123.
[Full Text]


Home page
NEJMHome page
R. Pathmanathan, U. Prasad, R. Sadler, K. Flynn, and N. Raab-Traub
Clonal Proliferations of Cells Infected with Epstein-Barr Virus in Preinvasive Lesions Related to Nasopharyngeal Carcinoma
N. Engl. J. Med., September 14, 1995; 333(11): 693 - 698.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
J. K. C. Chan, T. T. C. Yip, W. Y. W. Tsang, S. Seneviratne, Y.F. Poon, C. S. C. Wong, and V. W. S. Ma
Lack of Evidence of Pathogenetic Role of Epstein-Barr Virus in Thymic Lymphoid Hyperplasia and Thymomas in the Chinese Population of Hong Kong
International Journal of Surgical Pathology, July 1, 1994; 2(1): 17 - 22.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society for Investigative Pathology.